0001104659-23-082722.txt : 20230720
0001104659-23-082722.hdr.sgml : 20230720
20230720161551
ACCESSION NUMBER: 0001104659-23-082722
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230718
FILED AS OF DATE: 20230720
DATE AS OF CHANGE: 20230720
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Happel David
CENTRAL INDEX KEY: 0001623567
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41742
FILM NUMBER: 231099883
MAIL ADDRESS:
STREET 1: 7 HAMILTON LANDING
STREET 2: SUITE 100
CITY: NOVATO
STATE: CA
ZIP: 94949
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sagimet Biosciences Inc.
CENTRAL INDEX KEY: 0001400118
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 205991472
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 155 BOVET RD., SUITE 303
CITY: SAN MATEO
STATE: CA
ZIP: 94402
BUSINESS PHONE: (650) 561-8600
MAIL ADDRESS:
STREET 1: 155 BOVET RD., SUITE 303
CITY: SAN MATEO
STATE: CA
ZIP: 94402
FORMER COMPANY:
FORMER CONFORMED NAME: 3-V Biosciences, Inc.
DATE OF NAME CHANGE: 20070521
4
1
tm2321276-14_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2023-07-18
0
0001400118
Sagimet Biosciences Inc.
SGMT
0001623567
Happel David
SAGIMET BIOSCIENCES INC.
155 BOVET RD., SUITE 303
SAN MATEO
CA
94402
1
1
0
0
President & CEO
0
Stock Option (Right to Buy)
7.15
2023-07-18
4
D
0
1011826
0
D
2032-10-16
Common Stock
1011826
0
D
Stock Option (Right to Buy)
7.15
2023-07-18
4
A
0
1011826
0
A
2032-10-16
Series A Common Stock
1011826
1011826
D
Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock.
25% of the shares underlying this option shall vest and become exercisable on October 17, 2023, with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
/s/ Dennis Hom, Attorney-in-Fact
2023-07-20